Cosmetics: Collaborative program with HALLSTAR BEAUTY
In 2018, DEINOVE launched a collaborative program with OLÉOS (now HALLSTAR France) aimed at developing new 100% natural cosmetic active ingredients that combine the exclusive properties of DEINOVE bacteria with their patented oleo-eco-extraction technology.
A first ingredient marketed in 2020: BIOME Oléoactif®
BIOME Oléoactif® is the first ingredient obtained by capturing rare lipids from a wild extremophilic microorganism, then offering them to the skin and its microbiome. At the crossroads of bacterial and vegetable worlds, BIOME Oléoactif® both reinforces the integrity of the epidermal barrier and preserves the microbiota of healthy skin to prevent cutaneous discomfort and disease.
This active ingredient is produced by fermentation from an extremophilic microorganism from the DEINOVE collection and extracted by HALLSTAR BEAUTY's patented Oleo-eco-extraction process.
BIOME Oléoactif® is a COSMOS-certified natural beauty enhancer complex, totally safe with proven efficacy at low dose.
A second innovative ingredient under development with the support of the Occitanie region
A second active ingredient is in development, still in cosmetics and more particularly skin care. This program, which is supported by the Occitanie Region, aims at launching the product in 2021. The objective is to select certain DEINOVE bacteria for their valuable properties in cosmetics, to optimize the production in fermenters and to formulate a stable Oléoactif®, with clinically proven efficacy, easy to formulate and in line with the requirements of the cosmetics market.
DEINOVE works to optimize the production performance of the selected strains, while HALLSTAR formulates innovative ingredients by applying its extraction method to bacterial biomass. Patented in 2009, the oleo-eco-extraction process is an innovative and eco-certifiable technology, using no chemical or organic solvent, based on the solvent power of vegetable oils. An Oléoactif® is distinguished from a classic macerate by its high stability and its high concentration of active biomolecules. Each Oléoactive® is a unique and optimized synergy between a vegetable oil and a plant or, in the case of the active ingredients developed in collaboration with DEINOVE, bacterial biomass.
Cosmetics: Collaborative program with DOW
DEINOVE initiated in 2019 a collaboration with Dow for the joint development of an exclusive natural cosmetic ingredient.
Dow has selected an extract belonging to the DEINOVE proprietary strains’ bank to launch a new cosmetic active ingredient for skin care applications.
DEINOVE will now develop and optimize a dedicated production process and will ensure the industrial transposition and production of the developed cosmetic active. Leveraging its expertise and its cell biology laboratory in Belgium, Dow intends to qualify the cosmetic active and integrate it into its product portfolio, receiving commercial exclusivity worldwide. This compound is aligned with DOW’s strategy of expanding and transforming their portfolio dedicated to skin care. Commercialization is planned for early 2021.
Animal Nutrition: COLOR2B Program in collaboration with AVRIL
The COLOR2B program was launched in September 2014 in collaboration with Groupe AVRIL (ex. Sofiprotéol), the leading actor in the French oil and protein industry. It aims to develop a process for the production of natural additives for animal feed. In the long term, both partners aim to industrialize the bioproduction of such additives and to launch new ranges of products in animal nutrition.
Both partners announced that they successfully reached the first milestone of the project in May 2015 (fine selection of candidate strains). The second milestone, completed in April 2017, validated the efficacy and bioavailability of compounds produced from the 7 strains selected. The compounds produced by these strains, added to farm animal feed at the experimental station, have been assimilated by their organisms and have produced the desired effects.
The most successful strain was selected for different formulation tests. Whatever the formulation chosen, its performance proved to be comparable to that of products on the market, from petrochemicals. Test were conducted on different animal species in order to expand the commercial potential of this ingredient.
In June 2019, the partners confirmed the efficacy of the ingredient at a competitive dosage and that the regulatory and industrial stages are underway for marketing purposes.
Internal Research Programs
DEINOVE continues to explore the potential of the bacterial biodiversity of its proprietary collection.
Following the commercialization of Phyt-N-Resist and Luminity, two innovative active ingredients from the carotenoid family (a vast family of molecules known among other things for their antioxidant properties), other ingredients are in development. Some of them may be the subject of a partnership.